4 Stocks Pushing The Health Services Industry Lower
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 57 points (-0.4%) at 13,942 as of Monday, Feb. 25, 2013, 12:05 PM ET. The NYSE advances/declines ratio sits at 1,301 issues advancing vs. 1,576 declining with 144 unchanged.
The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Smith & Nephew ( SNN), down 1.2%, and Intuitive Surgical ( ISRG), down 0.4%. Top gainers within the industry include Opko Health ( OPK), up 4.0%, Mindray Medical International ( MR), up 1.9%, Cooper Companies ( COO), up 1.6%, Agilent Technologies ( A), up 0.6% and Baxter International ( BAX), up 0.6%.
TheStreet Ratings group would like to highlight 4 stocks pushing the industry lower today:
4. Fresenius Medical Care Corporation ( FMS) is one of the companies pushing the Health Services industry lower today. As of noon trading, Fresenius Medical Care Corporation is down $0.61 (-1.7%) to $34.40 on average volume Thus far, 122,944 shares of Fresenius Medical Care Corporation exchanged hands as compared to its average daily volume of 274,800 shares. The stock has ranged in price between $34.40-$34.82 after having opened the day at $34.80 as compared to the previous trading day's close of $35.01.
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides products and services for the treatment of end-stage renal disease worldwide. The company owns and operates dialysis clinics that provide dialysis treatment, and related laboratory and diagnostic services. Fresenius Medical Care Corporation has a market cap of $10.3 billion and is part of the health care sector. The company has a P/E ratio of 19.4, above the S&P 500 P/E ratio of 17.7. Shares are down 0.3% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Fresenius Medical Care Corporation a buy, no analysts rate it a sell, and 7 rate it a hold.
TheStreet Ratings rates Fresenius Medical Care Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Fresenius Medical Care Corporation Ratings Report now.